Oncaspar (pegaspargas) 3750MO/ml, 5 ml fl, India
Article:
VMPCSV-11
In Stock
Interchangeable drugs with the same active ingredient:
Oncaspar, hamsil
testimony
Oncaspar is indicated as a component of an antineoplastic combination therapy for the reinduction of remission in acute lymphatic leukemia (ALL) in pediatric and adult patients with known hypersensitivity to native L-asparaginase.
Oncospar recruitment errors
-
Commercial name:Oncaspar
-
Сhemical name:pegaspargasa
-
Dosage:3750MO/ml
-
Release form:Bottle
No reviews yet